The Hub for Disease-Specific Clinical Information
Advertisement
Advertisement

Stephanie Andrews, MS, ANP-BC, on Managing Toxicities of Immunotherapies

Posted: Friday, March 24, 2017

Stephanie Andrews, MS, ANP-BC, of the Moffitt Cancer Center, discusses the most common adverse events associated with immunotherapies in kidney cancer, melanoma, and lung cancer and reviews the recommended management approach for each.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.